{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:13:23Z","timestamp":1792451603479,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["202204295107020032"],"award-info":[{"award-number":["202204295107020032"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["9021898201"],"award-info":[{"award-number":["9021898201"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["1744"],"award-info":[{"award-number":["1744"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","award":["2022-LCYJ-PY-28"],"award-info":[{"award-number":["2022-LCYJ-PY-28"]}],"id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203728"],"award-info":[{"award-number":["82203728"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902415"],"award-info":[{"award-number":["81902415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.drup.2026.101409","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T14:50:41Z","timestamp":1777733441000},"page":"101409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting the USP5\u2013HSPB1 axis overcomes ferroptosis resistance in intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"87","author":[{"given":"Chengbin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingde","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shansu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panfeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruosen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-4542","authenticated-orcid":false,"given":"Zhangding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8113-4278","authenticated-orcid":false,"given":"Yin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101409_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2026.101409_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2026.101409_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drup.2026.101409_bib4","doi-asserted-by":"crossref","first-page":"15181","DOI":"10.1021\/jacs.4c18668","article-title":"Capturing the conformational heterogeneity of HSPB1 chaperone oligomers at atomic resolution","volume":"147","author":"Berkeley","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drup.2026.101409_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3324\/haematol.2020.259531","article-title":"APR-246 induces early cell death by ferroptosis in acute myeloid leukemia","volume":"107","author":"Birsen","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.drup.2026.101409_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.drup.2026.101409_bib7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41419-019-1814-8","article-title":"circHECTD1 facilitates glutaminolysis to promote gastric cancer progression by targeting miR-1256 and activating \u03b2-catenin\/c-Myc signaling","volume":"10","author":"Cai","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2026.101409_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116927","article-title":"Sodium butyrate increases USP5-mediated ubiquitination degradation of GPX4 and enhances anti-cancer efficacy of anti-PD-1 antibody","volume":"237","author":"Chang","year":"2025","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.drup.2026.101409_bib9","article-title":"NAT10 promotes gastric cancer liver metastasis by modulation of M2 macrophage polarization and metastatic tumor cell hepatic adhesion","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2026.101409_bib10","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/jn.00306.2022","article-title":"HSPB1 overexpression improves hypoxic-ischemic brain damage by attenuating ferroptosis in rats through promoting G6PD expression","volume":"128","author":"Dai","year":"2022","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.drup.2026.101409_bib11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","volume":"23","author":"Dewson","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101409_bib12","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101409_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117297","article-title":"Molecular glues and PROTACs in targeted protein degradation: mechanisms, advances, and therapeutic potential","volume":"242","author":"Eladl","year":"2025","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.drup.2026.101409_bib14","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.3168\/jds.2025-26265","article-title":"Heat shock protein B1-mediated ferroptosis regulates mitochondrial dysfunction in adipose tissue of ketotic dairy cows","volume":"108","author":"Fan","year":"2025","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.drup.2026.101409_bib15","article-title":"Blocking ubiquitin-specific protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl-CoA Desaturase","volume":"11","author":"Guan","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2026.101409_bib16","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1158\/0008-5472.CAN-10-1530","article-title":"Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis","volume":"70","author":"Kapuria","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2026.101409_bib17","article-title":"System X(c) (-)\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.drup.2026.101409_bib18","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.62347\/VJXX5513","article-title":"HSPB1 silencing enhances ferroptosis in glioma cells by suppressing BAG3 expression","volume":"17","author":"Li","year":"2025","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.drup.2026.101409_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2017.08.040","article-title":"USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein","volume":"492","author":"Li","year":"2017","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.drup.2026.101409_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41419-023-05972-0","article-title":"HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-\u03baB signaling pathway in breast cancer","volume":"14","author":"Liang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2026.101409_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41418-024-01407-1","article-title":"The AKR1C1-CYP1B1-cAMP signaling axis controls tumorigenicity and ferroptosis susceptibility of extrahepatic cholangiocarcinoma","volume":"32","author":"Liu","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.drup.2026.101409_bib22","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","article-title":"The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11","volume":"79","author":"Liu","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2026.101409_bib23","article-title":"COPS5 Triggers Ferroptosis Defense by Stabilizing MK2 in Hepatocellular Carcinoma","volume":"12","author":"Luo","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2026.101409_bib24","article-title":"Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential","author":"Mercado-G\u00f3mez","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.drup.2026.101409_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104557","article-title":"Structure and function of USP5: Insight into physiological and pathophysiological roles","volume":"157","author":"Ning","year":"2020","journal-title":"Pharm. Res"},{"key":"10.1016\/j.drup.2026.101409_bib26","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/j.drup.2026.101409_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13046-025-03564-8","article-title":"Pharmacological induction of acetyl-CoA carboxylase 1 autophagic degradation attenuates lipid accumulation and cholangiocarcinoma progression","volume":"44","author":"Pan","year":"2025","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101409_bib28","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1158\/0008-5472.CAN-24-0088","article-title":"Hypoxia Stimulates PYGB Enzymatic Activity to Promote Glycogen Metabolism and Cholangiocarcinoma Progression","volume":"84","author":"Pan","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2026.101409_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrgastro.2011.20","article-title":"Cholangiocarcinoma--controversies and challenges","volume":"8","author":"Patel","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drup.2026.101409_bib30","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.18632\/oncotarget.27196","article-title":"Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells","volume":"10","author":"Potu","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2026.101409_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13046-025-03548-8","article-title":"FASN inhibits ferroptosis in breast cancer via USP5 palmitoylation-dependent regulation of GPX4 deubiquitination","volume":"44","author":"Qian","year":"2025","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101409_bib32","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.bbadis.2018.02.013","article-title":"RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis","volume":"1864","author":"Qiu","year":"2018","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.drup.2026.101409_bib33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41419-025-08146-2","article-title":"USP5 regulates ferroptosis in colorectal cancer by targeting the YBX3\/SLC7A11 axis through lysosomal degradation","volume":"16","author":"Qiu","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2026.101409_bib34","article-title":"Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma","volume":"13","author":"Sae-Fung","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.drup.2026.101409_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70164","article-title":"Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS\/AML","volume":"9","author":"Sallman","year":"2025","journal-title":"Hemasphere"},{"key":"10.1016\/j.drup.2026.101409_bib36","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/s41467-025-56564-9","article-title":"USP5 stabilizes YTHDF1 to control cancer immune surveillance through mTORC1-mediated phosphorylation","volume":"16","author":"Shao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101409_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101409_bib38","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1038\/onc.2015.32","article-title":"HSPB1 as a novel regulator of ferroptotic cancer cell death","volume":"34","author":"Sun","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101409_bib39","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s12672-025-02803-w","article-title":"The role of HSPB1 in modulating ferroptosis in pancreatic cancer via the TP53\/SLC7A11\/GPX4 axis","volume":"16","author":"Tian","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.drup.2026.101409_bib40","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1002\/tox.24296","article-title":"STUB1 promotes the degradation of HSPB1 and induces ferroptosis in lung cancer cells","volume":"39","author":"Tieliwaerdi","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.drup.2026.101409_bib41","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.drup.2026.101409_bib42","article-title":"Advances in Ferroptosis Research: A Comprehensive Review of Mechanism Exploration, Drug Development, and Disease Treatment","volume":"18","author":"Wang","year":"2025","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.drup.2026.101409_bib43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.biocel.2017.08.001","article-title":"Inhibition of PARP1 activity enhances chemotherapeutic efficiency in cisplatin-resistant gastric cancer cells","volume":"92","author":"Wang","year":"2017","journal-title":"Int J. Biochem Cell Biol."},{"key":"10.1016\/j.drup.2026.101409_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101409_bib45","doi-asserted-by":"crossref","first-page":"21898","DOI":"10.1021\/acs.est.5c08855","article-title":"Revealing Ferroptosis Induction by Bisphenol A and Bisphenol S through Distinct Protein Targets","volume":"59","author":"Wang","year":"2025","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.drup.2026.101409_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13117","article-title":"Prognostic and predictive role of a metabolic rate-limiting enzyme signature in hepatocellular carcinoma","volume":"54","author":"Wang","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.drup.2026.101409_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41420-023-01459-1","article-title":"The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination","volume":"9","author":"Xia","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drup.2026.101409_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41420-021-00483-3","article-title":"Molecular mechanism of cell ferroptosis and research progress in regulation of ferroptosis by noncoding RNAs in tumor cells","volume":"7","author":"Xie","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drup.2026.101409_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103350","article-title":"Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors","volume":"76","author":"Xie","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.drup.2026.101409_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101246","article-title":"MVP-LCN2 axis triggers evasion of ferroptosis to drive hepatocarcinogenesis and sorafenib resistance","volume":"81","author":"Xu","year":"2025","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2026.101409_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.drup.2026.101409_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175265","article-title":"Induced protein degradation for therapeutics: past, present, and future","volume":"134","author":"Yoon","year":"2024","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.drup.2026.101409_bib53","article-title":"USP10 inhibits ferroptosis via deubiquinating POLR2A in head and neck squamous cell carcinoma","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2026.101409_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156708","article-title":"Scutellaria baicalensis extracts restrict intestinal epithelial cell ferroptosis by regulating lipid peroxidation and GPX4\/ACSL4 in colitis","volume":"141","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drup.2026.101409_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70018","article-title":"Gandouling ameliorates liver injury in Wilson's disease through the inhibition of ferroptosis by regulating the HSF1\/HSPB1 pathway","volume":"28","author":"Zhao","year":"2024","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.drup.2026.101409_bib56","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00031.2024","article-title":"Ferroptosis: when metabolism meets cell death","volume":"105","author":"Zheng","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.drup.2026.101409_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.drup.2026.101409_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101126","article-title":"crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer","volume":"77","author":"Zou","year":"2024","journal-title":"Drug Resist Updat"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:24:22Z","timestamp":1783117462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":58,"alternative-id":["S1368764626000609"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101409","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the USP5\u2013HSPB1 axis overcomes ferroptosis resistance in intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101409"}}